From custom corneal software house, to global refractive and therapeutic surgery playery.


LIGI Tecnologie Medicali began its extensive R&D program back in 1993, to implement the CIPTA® project for customized corneal surgery planning.

Founded by engineer Giuseppe D’Ippolito, our CEO, LIGI early recognized the potential in small spot scanning refractive lasers and the fundamental importance of the corneal shape for customized ablations to improve the quality of vision and minimize invasiveness.

LIGI always believed that proper planning of corneal refractive and therapeutic surgery needs to integrate a detailed knowledge of the corneal morphology and pupil dynamics, not relying solely on refractive data, like in standard ablations or Wavefront Guided treatments.


In 1996, after an extensive R&D project, CIPTA® software was launched and licensed to work with third party hardware


LIGI Tecnologie Medicali introduced in the market CLAT®, a software to customize corneal lamellar transplantation.


In 2001, LIGI started a comprehensive R&D program to create a full hardware and software platform to overcome the limitations of the technologies available on the market, which were not able to perform true customized, low-invasive, corneal surgery.


After 6 years of research and development in collaboration with several prestigious ophthalmic centers, the iVis Suite™ was born: an unique and coherent ensemble conceived to grant the surgeon the ability to plan and to execute  cTen™ (custom Trans epithelial no-touch) surgeries, to optimize patient quality of vision, to minimize treatment invasiveness and to avoid intra-operative risks.


iVis Technologies, a spin-off of LIGI Tecnologie Medicali, started operations in 2008 to manage, on a worldwide basis, marketing, sales and service of all the iVis Suite medical devices.


Market launch of CCR™ (Central Corneal Regularization), the planning software which combines customized central corneal regularization and cross-linking to improve quality of vision and contextually harden the corneal structure for the treatment of ectatic pathologies.


Market launch of MOD™ (Multifocal Optical Zone), the planning software for customized multifocal and full reversible refractive surgery for near and far vision.


Introduction of the Clinical Follow-up to monitor the evolution of the corneal pathologies.
Introduction of the Surgical Follow-up to evaluate, with an automated and objective closed loop control, the surgical outcomes of corneal refractive and therapeutic surgery.


iVerify™, the software to carry out a transparent and objective evaluation of the achieved surgical results vs. the intended surgical plan, was introduced in the market. iVerify™ is the unique software in the market which allows such transparent verification based on an A.I. analysis.


Market launch of DS&CEK™, the planning software to customize the donor lenticule for  endothelial lamellar transplantation.


Wi-Fi Transfer data introduction for the iVis Suite™ for a complete Remote Management of the customized surgical platform.


Patent of TES™ – Temporary Substitute of the corneal epithelium, a film of transparent, sterile and biocompatible self-adhesive hydrogel to eliminate post-operative pain in trans-epithelial corneal surgery, to improve quality of vision in the immediate post-op and to control the healing process.


Precisio II introduction in the market, the new generation tomographer granting a full automated exam acquisition and validation for advanced corneal diagnosis and custom corneal surgery.